Brazil was one of the hardest-hit nations by the COVID-19 pandemic on a global scale, ranking among the top thr🅰ee countries with the highest number of cas🀅es and deaths from the novel coronavirus. Brazil’s pharmaceutical industry, ...

Mexico is the second-largest pharmaceutical market in Latin America, after Brazil, with retail d𒅌rug sales of USD 7.3bn in 2019. The country has a growing and ageing population, multiple but underfunded state-run health insurance systems, ...

Argentina is the third-largest pharmaceutical market in Latin America, with ret🍨ail drug sales of USD 4.7bn in 2019. The country has a large and ageing population, a relatively developed public health system, and a small but consolidated ...

In a Latin American context, Chile is not a particularly large pharmaceutical and healthcare market, since its population is🎃 relatively small and healthy in terms of incidence of communicable diseases. However, the country’s changing ...

Peru is a comparatively small pharmaceutical market in Latin America (ranking eighth in terms of sales volume in 2018), with a relatively young and growing population. However, pꩵublic health spending is growing at a rapid pace, particularly in ...

Colombia was the fourth-largest pharmaceutical market in Latin America in terms of sales volume in 2018, with a large and growing popul✱ation, a universal but underfunded social security health insurance system, and a small but rapidly developing ...

In the past two decades, Latin America has embraced aಌ universal health strategy, based on the principles of equity, solidarity and collective action. This strategy required steadily growing public expenditure on health in order to guarantee universal ...

Due to a growing and ageing population, and an increasing incidence of non-comm𝔍unicable diseases, Brazil became the seventh largest pharmaceutical market in the world in 2018. During the year, retail drug sales, based on pharmacy purchase price (PPP) ...

Mexico is the second largest pharmaceutical market in Latin America, behind only Brazil, with retail drug sales of USD 10.2bn in 2018. The country also 𒆙features a ඣgrowing and ageing population, multiple but underfunded state-run health insurance ...

In a Latin American context, Chile is not💝 a particularly large pharmaceutical and healthcare market, since its population is relatively small and healthy in terms of the incidence of communicable diseases. However, the country&rsquo𝐆;s changing ...